don't worry if you don't have an account with us, we'll create one
[{"meta":{"author":"Oncology Today with Dr Neil Love","authorlink":""},"src":"https:\/\/aphid.fireside.fm\/d\/1437767933\/705f838e-4a61-494a-8050-bbbc7743dcc2\/8ed67a48-0c54-402d-830d-65b7bd6e3737.mp3","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202311\/d7c55b-0bfd-e625-9cfbc0_800.jpg"},"title":"Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer","link":"javascript:;","id":"item-121356429"},{"meta":{"author":"Oncology Today with Dr Neil Love","authorlink":""},"src":"https:\/\/aphid.fireside.fm\/d\/1437767933\/705f838e-4a61-494a-8050-bbbc7743dcc2\/d508a905-b1b7-4d27-8ba3-b0dbac2a665a.mp3","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202311\/d7c55b-0bfd-e625-9cfbc0_800.jpg"},"title":"Virtual Case Library: Metastatic Urothelial Bladder Cancer","link":"javascript:;","id":"item-120883956"},{"meta":{"author":"Oncology Today with Dr Neil Love","authorlink":""},"src":"https:\/\/aphid.fireside.fm\/d\/1437767933\/705f838e-4a61-494a-8050-bbbc7743dcc2\/76dc83ce-a64c-45da-bd5f-d8a1967310a6.mp3","thumb":{"src":"https:\/\/images.lystnfm.com\/tr:n-app_thumbnail_medium\/podcastsnw-202311\/d7c55b-0bfd-e625-9cfbc0_800.jpg"},"title":"Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer","link":"javascript:;","id":"item-120320737"}]